Irisin - A myth rather than an exercise-inducible myokine

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Albrecht, Elke ^a   Norheim, Frode ^b   Thiede, Bernd ^b   Holen, Torgeir ^b   Ohashi, Tomoo ^c   Schering, Lisa ^a   Lee, Sindre ^b   Brenmoehl, Julia ^a   Thomas, Selina ^d   Drevon, Christian A ^b   Erickson, Harold P ^c   Maak, Steffen ^a  

^a LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; FNDC5 PROTEIN, MOUSE;

ANIMAL; ARTIFACT; BLOOD; BLOOD ANALYSIS; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; EXERCISE; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; VALIDATION STUDY;

ANIMALS; ARTIFACTS; BLOOD CHEMICAL ANALYSIS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FIBRONECTINS; HUMANS; MICE; MUSCLE, SKELETAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84924390413     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08889     Document Type: Article

References (39)

1. Boström, P. et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468 (2012).
2. Ivanov, I. P., Firth, A. E.,Michel, A. M.,Atkins, J. F.&Baranov, P. V. Identification of evolutionarily conserved non-AUG-initiated N-terminal extensions in human coding sequences. Nucleic Acids Res. 39, 4220-4234 (2011).
3. Raschke, S. et al. Evidence against a beneficial effect of irisin in humans. PLOS ONE 8, e73680 (2013).
4. Timmons, J. A., Baar, K., Davidsen, P. K. & Atherton, P. J. Is irisin a human exercise gene? Nature 488, E9-10 (2012).
5. Huh, J. Y. et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725-1738 (2012).
6. Kraemer, R. R., Shockett, P.,Webb, N. D., Shah, U. & Castracane,V. D.Atransient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Horm. Metab. Res. 46, 150-154 (2014).
7. Tsuchiya, Y. et al.High-Intensity exercise causes greater irisin response compared with low-intensity exercise under similar energy consumption. Tohoku J. Exp. Med. 233, 135-140 (2014).
8. Anastasilakis, A. D. et al. Circulating irisin in healthy, young individuals: Daynight rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet and body composition. J. Clin. Endocrinol. Metab. 99, 3247-3255 (2014).
9. Daskalopoulou, S. S. et al. Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects. Eur. J. Endocrinol. 171, 343-352 (2014).
10. Pekkala, S. et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J. Physiol. 591, 5393-5400 (2013).
11. Hecksteden, A. et al. Irisin and exercise training in humans - Results from a randomized controlled training trial. BMC Med. 11, 235 (2013).
12. Kurdiova, T. et al. Are skeletal muscle & adipose tissue Fndc5 gene expression and irisin release affected by obesity, diabetes and exercise? In vivo & in vitro studies. J. Physiol. 592, 1091-1107 (2014).
13. Norheim, F. et al. The effects of acute and chronic exercise on PGC-1 a, irisin and browning of subcutaneous adipose tissue in human. FEBS J. 281, 739-749 (2014).
14. Hofmann, T. et al. Irisin levels are not affected by physical activity in patients with anorexia nervosa. Front. Endocrinol. (Lausanne) 4, 202 (2014).
15. Scharhag-Rosenberger, F. et al. Irisin does not mediate resistance traininginduced alterations in RMR. Med. Sci. Sports Exerc. 46, 1736-1743 (2014).
16. Alvehus, M., Boman, N., Söderlund, K., Svensson, M. B. & Buré n, J. Metabolic adaptations in skeletal muscle, adipose tissue, and whole-body oxidative capacity in response to resistance training. Eur. J. Appl. Physiol. 114, 1463-1471 (2014).
17. Ellefsen, S. et al. Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women. Eur. J. Appl. Physiol. 114, 1875-1888 (2014).
18. Erickson, H. P. Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor? Adipocyte 2, 289-293 (2013).
19. Sharma, N., Castorena, C. M. & Cartee, G. D. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines. Nutr. Metab. (Lond) 9, 90 (2013).
20. Wen, M. S., Wang, C. Y., Lin, S. L. & Hun, K. C. Decrease in irisin in patients with chronic kidney disease. PLOS ONE 8, e64025 (2013).
21. Roca-Rivada, A. et al. FNDC5/Irisin is not only a myokine but also an adipokine. PLOS ONE 8, e60563 (2013).
22. Lee, P. et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 19, 302-309 (2014).
23. Brenmoehl, J. et al. Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise. Int. J. Biol. Sci. 10, 338-349 (2014).
24. Komolka, K. et al. Locus characterization and gene expression of bovine FNDC5: Is the myokine irisin relevant in cattle? PLOS ONE 9, e88060 (2014).
25. Sanchis-Gomar, F., Alis, R., Pareja-Galeano, H., Romagnoli, M. & Perez-Quilis, C. Inconsistency in Circulating Irisin Levels: What is Really Happening? Horm. Metab. Res. 46, 591-596 (2014).
26. Elsen, M., Raschke, S. & Eckel, J. Browning of white fat: does irisin play a role in humans? J. Endocrinol. 222, R25-38 (2014).
27. Wrann, C. D. et al. Exercise induces hippocampal BDNF through a PGC-1α/ FNDC5 pathway. Cell Metab. 18, 649-659 (2013).
28. Elsen, M., Raschke, S., Sommerfeld,M., Gassenhuber, H. & Eckel, J. Comment on Wu and Spiegelman. Irisin ERKs the Fat. Diabetes 63, 381-383 (2014).
29. Diabetes 63, e16 (2014).
30. Spiegelman, B. M. & Wrann, C. Response to comment on Wu and Spiegelman. Irisin ERKs the Fat. Diabetes 63, 381-383 (2014).
31. Diabetes 63, e17 (2014).
32. Choi, H. Y. et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J. Clin. Endocrinol. Metab. 99, 2778-2785 (2014).
33. Zhang, Y. et al . Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 63, 514-525 (2014).
34. Atherton, P. J. & Phillips, B. E. Greek goddess or Greek myth: the effects of exercise on irisin/FNDC5 in humans. J. Physiol. 591, 5267-5268 (2013).
35. Lösel, D., Franke, A. & Kalbe, C. Comparison of different skeletal muscles from growing domestic pigs and wild boars. Arch. Tierz. 56, 76 (2013).
36. Schumacher, M. A., Chinnam, N., Ohashi, T., Shah, R. S. & Erickson, H. P. The structure of irisin reveals a novel intersubunit b-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. J. Biol. Chem. 288, 33738-33744 (2013).
37. Miroux, B.&Walker, J. E. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J. Mol. Biol. 260, 289-298 (1996).
38. Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30, 918-920 (2012).
39. Li, Y. et al. Subsarcolemmal lipid droplet responses to a combined endurance and strength exercise intervention. Physiol. Rep. 2, e12187 (2014).